Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
24 studies found for:    "Klebsiella"
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Condition: Klebsiella Pneumoniae Carbapenemase Resistant Associated Bacteremia or Pneumonia
Interventions: Drug: Colistin (Polymyxin E) 100mg x 4/d;   Drug: both medications;   Drug: will not receive PO treatment;   Drug: PO Garamycin 80mg x 4/d
2 Unknown  Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia
Conditions: Anti-Biotic Resistance;   Klebsiella Pneumoniae
Interventions: Dietary Supplement: VSL#3;   Drug: Polyethylene glycol
3 Completed Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections
Conditions: Carbapenem;   Klebsiella Pneumonia
Intervention: Other: none intervention
4 Active, not recruiting Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
Conditions: Quinolone Resistance;   ESBL;   Klebsiella Species;   Infection
5 Completed Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
Conditions: Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: vancomycin-resistant enterococci and ESBL
6 Completed Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin
Condition: Patients Colonized by Klebsiella Pneumoniae.
Interventions: Drug: Neomycin;   Drug: Streptomycin;   Drug: Gentamicins
7 Unknown  SDD for Eradicating CRKP Carriage
Condition: Carriers of Carbapenem-resistant Klebsiella Pneumonia
Intervention: Device: Gentamicin and polymyxin E
8 Completed Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
Conditions: Escherichia Coli Infections;   Klebsiella Pneumonia
9 Completed Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features
Condition: Necrotizing Fasciitis
10 Recruiting Antibiotics for Klebsiella Liver Abscess Study
Condition: Liver Abscess, Pyogenic
Interventions: Drug: Ciprofloxacin;   Drug: Ceftriaxone;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Ertapenem
11 Completed Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Conditions: Gram-Positive Bacterial Infections;   Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: piperacillin-tazobactam
12 Completed Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
Condition: Carriage of Carbapemen-resistant Klebsialle Pneumoniae
Intervention: Drug: Arm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo.
13 Recruiting RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.
Condition: Bloodstream Infections
Interventions: Drug: Meropenem;   Drug: Piperacillin-tazobactam combination product
14 Unknown  Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers
Condition: Bacterial Colonization
Interventions: Drug: Lactitol;   Drug: Lactobacillus
15 Completed Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Conditions: Infection;   E Coli Infections;   Klebsiella Infections;   Proteus Infections
16 Unknown  Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
Condition: Infections
Intervention: Drug: Colistin
17 Completed The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy
Condition: End-stage Renal Disease
Intervention: Other: renal replacement therapy
18 Recruiting Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
Conditions: Anti-Infective Agents, Urinary;   Escherichia Coli Infections;   Klebsiella Infections;   Kidney Transplantation;   Urinary Tract Infections
Interventions: Drug: Sitafloxacin;   Drug: Ertapenem
19 Completed Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis
Condition: Community Acquired Infection
Intervention: Other: bacteremia caused by ESBL producing E.coli or K.pneumoniae
20 Completed Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
Condition: Gram-Negative Bacterial Infections
Intervention: Drug: tigecycline

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.